Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)

PHASE2TerminatedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

March 7, 2019

Study Completion Date

March 7, 2019

Conditions
Post-herpetic Neuralgia
Interventions
DRUG

EMA401

EMA401

DRUG

Placebo

Placebo

Trial Locations (58)

2143

Novartis Investigative Site, Kistarcsa

2500

Novartis Investigative Site, Esztergom

3000

Novartis Investigative Site, Melbourne

3212

Novartis Investigative Site, Pellenberg

6725

Novartis Investigative Site, Szeged

9020

Novartis Investigative Site, Klagenfurt

10435

Novartis Investigative Site, Berlin

24105

Novartis Investigative Site, Kiel

24119

Novartis Investigative Site, Kiel

45147

Novartis Investigative Site, Essen

56501

Novartis Investigative Site, Choceň

59037

Novartis Investigative Site, Lille Cédex

63000

Novartis Investigative Site, Clermont-Ferrand

65191

Novartis Investigative Site, Wiesbaden

70403

Novartis Investigative Site, Tainan City

85540

Novartis Investigative Site, Haar

91054

Novartis Investigative Site, Erlangen

92104

Novartis Investigative Site, Boulogne-Billancourt

A-1160

Novartis Investigative Site, Vienna

L4J 1W3

Novartis Investigative Site, Ontario

G6W 5M6

Novartis Investigative Site, Lévis

G3K 2P8

Novartis Investigative Site, Québec

615 00

Novartis Investigative Site, Brno

305 99

Novartis Investigative Site, Plzen-Bory

100 00

Novartis Investigative Site, Prague

DK 5000

Novartis Investigative Site, Odense C

06003

Novartis Investigative Site, Nice

01307

Novartis Investigative Site, Dresden

04109

Novartis Investigative Site, Leipzig

00185

Novartis Investigative Site, Rome

663 8014

Novartis Investigative Site, Nishinomiya

241-0022

Novartis Investigative Site, Yokohama

244-0816

Novartis Investigative Site, Yokohama

245-8575

Novartis Investigative Site, Yokohama

593-8324

Novartis Investigative Site, Sakai

Unknown

Novartis Investigative Site, Kawaguchi

Novartis Investigative Site, Ōita

420-0839

Novartis Investigative Site, Shizuoka

343-0012

Novartis Investigative Site, Kasukabe-shi

154-0015

Novartis Investigative Site, Setagaya Ku

0450

Novartis Investigative Site, Oslo

10 561

Novartis Investigative Site, Olsztyn

00 144

Novartis Investigative Site, Warsaw

2801 951

Novartis Investigative Site, Almada

3814-501

Novartis Investigative Site, Aveiro

2410-187

Novartis Investigative Site, Leiria

1500 650

Novartis Investigative Site, Lisbon

4099-001

Novartis Investigative Site, Porto

018 41

Novartis Investigative Site, Dubnica nad Váhom

974 04

Novartis Investigative Site, Banská Bystrica

08001

Novartis Investigative Site, Prešov

05201

Novartis Investigative Site, Spišská Nová Ves

463-712

Novartis Investigative Site, Seongnam-si

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

08025

Novartis Investigative Site, Barcelona

DL3 6HX

Novartis Investigative Site, Darlington

SW10 9NH

Novartis Investigative Site, London

L9 7LJ

Novartis Investigative Site, Liverpool

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY